Editorial: Epigenetic Therapy With Histone Deacetylase Inhibitors: Implications for Cancer Treatment

dc.contributorUniv Beira Interior
dc.contributorUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2021-06-25T15:02:38Z
dc.date.accessioned2022-12-19T23:02:31Z
dc.date.available2021-06-25T15:02:38Z
dc.date.available2022-12-19T23:02:31Z
dc.date.created2021-06-25T15:02:38Z
dc.date.issued2021-04-06
dc.identifierFrontiers In Cell And Developmental Biology. Lausanne: Frontiers Media Sa, v. 9, 2 p., 2021.
dc.identifier2296-634X
dc.identifierhttp://hdl.handle.net/11449/210247
dc.identifier10.3389/fcell.2021.662761
dc.identifierWOS:000641259200001
dc.identifier1768025290373669
dc.identifier0000-0003-1740-7360
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/5390847
dc.languageeng
dc.publisherFrontiers Media Sa
dc.relationFrontiers In Cell And Developmental Biology
dc.sourceWeb of Science
dc.subjectcancer treatment
dc.subjectcellular mechanisms
dc.subjectdrugs
dc.subjectepigenetics
dc.subjecthistone deacetylase inhibitors
dc.subjectmolecular biology
dc.titleEditorial: Epigenetic Therapy With Histone Deacetylase Inhibitors: Implications for Cancer Treatment
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución